220
Participants
Start Date
January 31, 2007
Primary Completion Date
February 28, 2011
Study Completion Date
February 28, 2011
placebo
Placebo
pregabalin
Pregabalin capsules taken twice daily up to 17 weeks (150-600 mg/day)
Pfizer Investigational Site, Hong Kong
Pfizer Investigational Site, España
Pfizer Investigational Site, Quezon City
Pfizer Investigational Site, New York
Pfizer Investigational Site, White Plains
Pfizer Investigational Site, Prague
Pfizer Investigational Site, Johnstown
Pfizer Investigational Site, Philadelphia
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, Orlando
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Bellevue
Pfizer Investigational Site, Liberec
Pfizer Investigational Site, Indianapolis
Pfizer Investigational Site, Detroit
Pfizer Investigational Site, Overland Park
Pfizer Investigational Site, Brno
Pfizer Investigational Site, Dallas
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Phoenix
Pfizer Investigational Site, Pasadena
Pfizer Investigational Site, Northridge
Pfizer Investigational Site, Fresno
Pfizer Investigational Site, Napa
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Beijing
Pfizer Investigational Site, Moscow
Pfizer Investigational Site, Saint Petersburg
Pfizer Investigational Site, Mangalore
Pfizer Investigational Site, Chengdu
Pfizer Investigational Site, Viña del Mar
Pfizer Investigational Site, Medellín
Pfizer Investigational Site, Nagoya
Pfizer Investigational Site, Daisen
Pfizer Investigational Site, Iizuka
Pfizer Investigational Site, Fukuyama
Pfizer Investigational Site, Bibai
Pfizer Investigational Site, Hakodate
Pfizer Investigational Site, Sapporo
Pfizer Investigational Site, Kobe
Pfizer Investigational Site, Sasima-gun
Pfizer Investigational Site, Kawasaki
Pfizer Investigational Site, Kikuchi-gun
Pfizer Investigational Site, Sendai
Pfizer Investigational Site, Kashiwazaki
Pfizer Investigational Site, Beppu
Pfizer Investigational Site, Hanyū
Pfizer Investigational Site, Kitamoto
Pfizer Investigational Site, Hamamatsu
Pfizer Investigational Site, Kanuma
Pfizer Investigational Site, Kotoku
Pfizer Investigational Site, Musashimurayama-shi
Pfizer Investigational Site, Higashiokitama-gun
Pfizer Investigational Site, Chiba
Pfizer Investigational Site, Tokushima
Pfizer Investigational Site, Yamagata
Pfizer Investigational Site, Cebu City
Pfizer Investigational Site, Manila
Pfizer Investigational Site, Secunderabad
Pfizer Investigational Site, Bangalore
Pfizer Investigational Site, Bangalore
Pfizer Investigational Site, Lucknow
Pfizer Investigational Site, New Delhi
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY